PRESS




DECEMBER 5, 2013
CardioComm Solutions' HeartCheck? Technologies to be used in Canadian Parkinson's Research Study
TORONTO, ONTARIO - CardioComm Solutions, Inc. announced it shall be providing HeartCheck™ SMART Monitoring ECG services at no cost effective December 10, 2013 for its USA based customers who have been provided a HeartCheck™ device under a physician prescription.


OCTOBER 17, 2013
CardioComm Solutions' HeartCheckTM ECG Screening Technologies Superior to Pulse Check for Atrial Fibrillation Screening and Detection
TORONTO, ONTARIO - CardioComm Solutions, Inc. confirms results from the use of the HeartCheck™ ECG Monitor were presented today at Vascular 2013 in Montreal. Researchers from three University of Toronto teaching hospitals and the Centre for Innovation in Complex Care developed the protocol for the national program that screened for Atrial Fibrillation ("AF") as a risk factor for stroke in 1,334 participants.


OCTOBER 10, 2013
CardioComm Solutions' HeartCheck™ Technologies to be used in Canadian Clinical Arrhythmia Risk Screening and Stoke Prevention Trial.
TORONTO, ONTARIO - CardioComm Solutions, Inc. announced it is working with the Canadian Atrial Fibrillation Stroke Prevention Intervention Network ("CSPIN") as the ECG screening solutions provider for their research study entitled, "Program for the Identification of 'Actionable' Atrial Fibrillation ('PIAAF'): Systematic Screening to Detect Previously Undiagnosed or Untreated AF in the Community".


OCTOBER 7, 2013
CardioComm Solutions Starts OTC HeartCheck™ PEN Pharmacy Sales, Supported by Launch of New HeartCheck™ "Take Control" Television Commercial Campaign
TORONTO, ONTARIO - CardioComm Solutions, Inc. announced that it has launched a television commercial campaign to promote awareness of the HeartCheck™ PEN and signaling its availability for sale in select pharmacies. The commercials will air on the CBC television network commencing October 7, 2013 and will focus on the Southern Ontario viewing audience.


SEPTEMBER 16, 2013
CardioComm Solutions HeartCheck™ ECG PEN Featured in October Edition of Zoomer Magazine
TORONTO, ONTARIO - CardioComm Solutions, Inc. is pleased to announce that the HeartCheck™ PEN ECG device and SMART Monitoring service were the subject of a special article in the October 2013 issue of Zoomer Magazine, published by ZoomerMedia Limited.


AUGUST 20, 2013
CardioComm Solutions Releases GEMS Home Upgrade in Support of the HeartCheckTM PEN ECG and SMART Monitoring Technologies
TORONTO, ONTARIO - CardioComm Solutions, Inc. confirms it has released a new version of its GEMS Home software which is available to both new purchasers of the HeartCheck™ PEN ECG device as well as a free upgrade to current HeartCheck™ PEN owners.


AUGUST 19, 2013
SunGard Availability Services Recognizes CardioComm Solutions' Cloud-Based HeartCheck™ SMART Monitoring Platform
TORONTO, ONTARIO - CardioComm Solutions, Inc. confirmed SunGard Availability Services (Canada) Ltd, a subsidiary of SunGard Data Systems Inc. ("SunGard'), will be promoting CardioComm Solutions in a case study related to the Company's use of their cloud-based systems infrastructure as the platform for the HeartCheckTM-based SMART Monitoring service.


JULY 11, 2013
CardioComm Solutions' HeartCheck™ PEN ECG to be used in Clinical Monitoring for Arrhythmia Risk Screening and QT interval Prolongation
TORONTO, ONTARIO - CardioComm Solutions, Inc. announced it is working with clinicians at Sunnybrook Hospital in Toronto to use the HeartCheck™ PEN handheld ECG device and SMART Monitoring service to monitor patients for ECG changes that may result in sudden cardiac death. The HeartCheck™ PEN ECG was also cited in the lead article of the July 2013 North American circular "Congenital Cardiology Today".


MAY 9, 2013
CardioComm Solutions Files New Patents for Automated Enabling of Over-The-Counter, Consumer, Bio-Monitoring Devices for Home Monitoring and Remote Diagnostic Interpretation.
TORONTO, ONTARIO - CardioComm Solutions, Inc. confirmed it has filed for U.S. and Canadian patents for use of their proprietary technologies in the automated, software enabled and server based unlocking of over-the-counter ("OTC"), consumer based, bio-monitoring devices.


APRIL 24, 2013
CardioComm Solutions Establishes 30 Minute ECG Reporting Response Times as HeartCheck PEN Sales and SMART Monitoring Service Demand Grows
TORONTO, ONTARIO - CardioComm Solutions, Inc. formally announced expansion of the Company's SMART Monitoring Service and infrastructure to meet consumer demand for faster ECG interpretation services.